Balance Sheet Data
Ekso Bionics Holdings, Inc. (EKSO)
$1.75
+0.05 (+2.94%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 7.66 | 10.87 | 12.86 | 40.41 | 20.53 | 22.35 | 23.92 | 25.60 | 27.39 | 29.31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 3.66 | 5.21 | 3.39 | 4.66 | 4.63 | 5.12 | 5.48 | 5.86 | 6.27 | 6.71 |
| Account Receivables (%) | ||||||||||
| Inventories | 3.37 | 2.49 | 1.98 | 2.24 | 5.19 | 3.59 | 3.84 | 4.11 | 4.40 | 4.71 |
| Inventories (%) | ||||||||||
| Accounts Payable | 3.16 | 1.90 | 1.50 | 3.11 | 3.15 | 3.05 | 3.27 | 3.50 | 3.74 | 4 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -0.13 | -0.06 | -0.07 | -0.09 | -0.10 | -0.11 | -0.12 | -0.13 | -0.13 | -0.14 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.